TrianglePUBLICATIONS · 20368561
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2010 May 1
- First author
- Mateos MV
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Mateos MV
- type
- Author
- name
- Richardson PG
- type
- Author
- name
- Schlag R
- type
- Author
- name
- Khuageva NK
- type
- Author
- name
- Dimopoulos MA
- type
- Author
- name
- Shpilberg O
- type
- Author
- name
- Kropff M
- type
- Author
- name
- Spicka I
- type
- Author
- name
- Petrucci MT
- type
- Author
- name
- Palumbo A
- type
- Author
- name
- Samoilova OS
- type
- Author
- name
- Dmoszynska A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Mateos MV
- type
- Author
- name
- Richardson PG
- type
- Author
- name
- Schlag R
- type
- Author
- name
- Khuageva NK
- type
- Author
- name
- Dimopoulos MA
- type
- Author
- name
- Shpilberg O
- type
- Author
- name
- Kropff M
- type
- Author
- name
- Spicka I
- type
- Author
- name
- Petrucci MT
- type
- Author
- name
- Palumbo A
- type
- Author
- name
- Samoilova OS
- type
- Author
- name
- Dmoszynska A
- type
- Author
- bibliography ids
- nci-bib-9fabc07ecd0ceffd0fddaac4
- book metadata
- content sha256
- 79abcd492331b670b533f57346d74d5ad413a1f54dd90b3d1ff92a4f40be63d2
- document type
- citation
- dois
- 10.1200/JCO.2009.26.0638
- electronic publication date
- display
- 2010 Apr 5
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:20368561
- immutable id
- pubmed:20368561@79abcd492331b670b533f57346d74d5ad413a1f54dd90b3d1ff92a4f40be63d2
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 13
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2259-66
- volume
- 28
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 20368561
- provenance
- batch id
- bce21fa556c206e375c2
- provider
- NCBI PubMed ESummary
- record sha256
- fe7724fddffab591fac658b0adbe44e712ac0fe51a7264dd5a97d303f0c38c3f
- response sha256
- 280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
- retrieved at
- 2026-09-09T23:46:33.526275+00:00
- publication date
- display
- 2010 May 1
- precision
- day
- year
- 2010
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial.
Preserved source evidence · Not medical advice